title: Feasibility of HIV Pre-Exposure Prophylaxis as Part of Routine Care in Toronto, Canada.
authors.affiliation: *Department of Medicine, University of Toronto, Toronto, ON, Canada †Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada ‡Immunodeficiency Clinic, Toronto General Hospital, Toronto, ON, Canada §Divisions of Internal Medicine and Infectious Diseases, University Health Network, Toronto, ON, Canada.
authors.forename: Jason
authors.initials: J
authors.lastname: Rajchgot
authors.forename: Reed A C
authors.initials: RA
authors.lastname: Siemieniuk
authors.forename: Nirojini
authors.initials: N
authors.lastname: Sivachandran
authors.forename: Pauline
authors.initials: P
authors.lastname: Murphy
authors.forename: Andrea
authors.initials: A
authors.lastname: Sharp
authors.forename: Angela
authors.initials: A
authors.lastname: Cicci
authors.forename: Isaac I
authors.initials: II
authors.lastname: Bogoch
mesh_terms: D000284:Administration, Oral; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D002170:Canada; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination / Q000008:administration & dosage*; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D065129:Pre-Exposure Prophylaxis; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination